The special conditions of MDx use in the pediatric market may also present advantages in patient satisfaction metrics, a BioFire representative said.
The firm received CLIA waiver of a strep A assay on its Liat platform yesterday, and a favorable evaluation of its influenza A/B assay was published last week.
Three new assays were presented in posters at April's Clinical Virology Symposium.
Scientists in British Columbia are setting up a genomic surveillance system for avian influenza.
In Science this week: self-assembly of DNA components in solution, and more.
Genome sequences from hundreds of H7N9 isolates in China traced the movement of viruses responsible for a second wave of human infections in the country.
The RT-PCR/ESI-MS system showed similar sensitivity and specificity to tests from Cepheid and Hologic.
The firm is focused on moving more of its business into the molecular diagnostics market, and it believes the recent CLIA waiver for its Alere i platform provides it with a market opportunity not available to competitors.
With overlapping technologies, some firms pursue parallel human and animal health diagnostics development, but cost constraints and regulatory dynamics differ. Part one of a two-part series.
The New York Times looks at companies using genomic tools to try to quickly identify the cause of patients' infections.
The White House has asked for $2.5 billion in funding to address the COVID-19 outbreak, according to the Associated Press.
A resignation at the Marine Biological Laboratory highlights that institutions are unsure of how to handle researchers previously found to have violated codes of conduct, Nature News says.
In PNAS this week: immune responses that affect heart transplant rejection risk, gene variants associated with thiopurine toxicity, and more.